Manpei Suzuki Diabetes Foundation announces the 2009 winner of International Prize

The Manpei Suzuki Diabetes Foundation is pleased to announce the 2009 winner of the International Prize: Donald F. Steiner, MD, A. N. Pritzker Distinguished Service Professor Emeritus, Departments of Medicine and Biochemistry and Molecular Biology, The University of Chicago, USA.

The Prize was inaugurated in 2008 to commemorate the 15th anniversary of the Manpei Suzuki Diabetes Foundation, honoring those who have enlightened researchers in the field of diabetes around the world with their original and excellent scientific achievements.

Dr. Steiner will be awarded a Certificate of Honor, US$150,000, and a Japanese objet d'art at the award ceremony on March 2, 2010. On this day, we are honored to have the prize laureate, Donald F. Steiner, MD, present a commemorative lecture.

The Selection Committee of the Manpei Suzuki Diabetes Foundation recognizes the outstanding achievements of Dr. Donald F. Steiner over many years of research: the discovery of proinsulin and characterization of the proinsulin processing pathway, clinical applications of C-peptide radioimmunoassay for measuring endogenous insulin production, and identification of a point mutation in the insulin gene causing various abnormalities in glucose metabolism. He has greatly contributed to our increased understanding in the mechanism of insulin secretion and related disorders.

The Manpei Suzuki Diabetes Foundation hopes to contribute in advancing diabetes research with this yearly prize, enabling greater interchanges of ideas to fight this most prevalent disease.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New therapy from UI Health becomes the first FDA-approved treatment for brittle type 1 diabetes